ICH adopts guidelines on viral safety evaluation and analytical method development
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)GlobalPharmaceuticalsProduct developmentProduct LifecycleQuality Assurance and ControlRegulatory Intelligence/Policy